High-performance liquid chromatographic method for the quantitation of a meta-O-dealkylated metabolite of flecainide acetate, a new antiarrhythmic.
暂无分享，去创建一个
[1] J. Johnson,et al. Quantitation of flecainide acetate, a new antiarrhythmic agent, in biological fluids by gas chromatography with electron-capture detection. , 1984, Journal of pharmaceutical sciences.
[2] J. Johnson,et al. Biotransformation and elimination of 14C-flecainide acetate in humans. , 1984, Drug metabolism and disposition: the biological fate of chemicals.
[3] L. Wilkins. Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial. , 1983, Circulation.
[4] R. Asinger,et al. Suppression of Ventricular Ectopic Depolarizations by Flecainide Acetate, A New Antiarrhythmic Agent , 1982, Circulation.
[5] D. Roden,et al. Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide. , 1981, The American journal of cardiology.
[6] B. Pitt,et al. Oral flecainide acetate for the treatment of ventricular arrhythmias. , 1981, The New England journal of medicine.
[7] A. Miller,et al. Application of a bonded-phase extraction column for rapid sample preparation of flecainide from human plasma for high-performance liquid chromatographic analysis--fluorescence or ultraviolet detection. , 1984, Therapeutic drug monitoring.
[8] A. Miller,et al. Determination of Flecainide in Human Plasma by High Performance Liquid Chromatography with Fluorescence Detection , 1984 .